KR101272139B1 - 국소 적용용 체내기생충 구제제 - Google Patents

국소 적용용 체내기생충 구제제 Download PDF

Info

Publication number
KR101272139B1
KR101272139B1 KR1020067014014A KR20067014014A KR101272139B1 KR 101272139 B1 KR101272139 B1 KR 101272139B1 KR 1020067014014 A KR1020067014014 A KR 1020067014014A KR 20067014014 A KR20067014014 A KR 20067014014A KR 101272139 B1 KR101272139 B1 KR 101272139B1
Authority
KR
South Korea
Prior art keywords
spp
alkyl
species
praziquantel
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067014014A
Other languages
English (en)
Korean (ko)
Other versions
KR20060103953A (ko
Inventor
벤카타-랑가라오 카니칸티
토마스 바흐
게르트라우트 알트로이터
미카엘 트로이벨
한스-위르겐 하만
Original Assignee
바이엘 인텔렉쳐 프로퍼티 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 인텔렉쳐 프로퍼티 게엠베하 filed Critical 바이엘 인텔렉쳐 프로퍼티 게엠베하
Publication of KR20060103953A publication Critical patent/KR20060103953A/ko
Application granted granted Critical
Publication of KR101272139B1 publication Critical patent/KR101272139B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020067014014A 2003-12-13 2004-11-30 국소 적용용 체내기생충 구제제 Expired - Fee Related KR101272139B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation
DE10358525.7 2003-12-13
PCT/EP2004/013552 WO2005055973A2 (de) 2003-12-13 2004-11-30 Endoparasitizide mittel zur topischen applikation

Publications (2)

Publication Number Publication Date
KR20060103953A KR20060103953A (ko) 2006-10-04
KR101272139B1 true KR101272139B1 (ko) 2013-06-10

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067014014A Expired - Fee Related KR101272139B1 (ko) 2003-12-13 2004-11-30 국소 적용용 체내기생충 구제제

Country Status (31)

Country Link
US (1) US7763583B2 (https=)
EP (1) EP1694291B1 (https=)
JP (1) JP4842141B2 (https=)
KR (1) KR101272139B1 (https=)
CN (1) CN1893919B (https=)
AR (1) AR046878A1 (https=)
AT (1) ATE447940T1 (https=)
AU (1) AU2004296537B2 (https=)
BR (1) BRPI0417578B1 (https=)
CA (1) CA2548897C (https=)
CR (1) CR8428A (https=)
DE (2) DE10358525A1 (https=)
DK (1) DK1694291T3 (https=)
ES (1) ES2334920T3 (https=)
GT (1) GT200400264A (https=)
HR (1) HRP20100056T1 (https=)
IL (1) IL176151A (https=)
MX (1) MXPA06006594A (https=)
MY (1) MY142044A (https=)
NO (1) NO20063171L (https=)
NZ (1) NZ547837A (https=)
PE (1) PE20050919A1 (https=)
PL (1) PL1694291T3 (https=)
PT (1) PT1694291E (https=)
RU (1) RU2401108C2 (https=)
SI (1) SI1694291T1 (https=)
TW (1) TWI341202B (https=)
UA (1) UA85574C2 (https=)
UY (1) UY28662A1 (https=)
WO (1) WO2005055973A2 (https=)
ZA (1) ZA200604744B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010042395A1 (en) * 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
CA2751854A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
CN104023710A (zh) * 2011-12-21 2014-09-03 拜耳知识产权有限责任公司 包含无定形艾默德斯的制剂
BR112015014266B1 (pt) * 2012-12-18 2021-01-26 Donaghys Limited formulação parasiticida transdermal na forma de uma solução
KR20160115993A (ko) * 2014-02-14 2016-10-06 디에스엠 아이피 어셋츠 비.브이. 주혈흡충병의 예방 및/또는 치료를 위한 조성물 및 방법
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
BR112018013369A2 (pt) 2015-12-28 2019-02-19 Merial, Inc. compostos depsipeptídicos anti-helmínticos
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
IL274283B2 (en) 2017-11-07 2025-03-01 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010109527A (ko) * 1999-05-12 2001-12-10 빌프리더 하이더 사이클릭 뎁시펩타이드 및 피페라진을 함유하는내부기생충 구제용 상승적 배합물
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
KR20020058023A (ko) * 1999-11-18 2002-07-12 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 살충성 아미노헤테로시클릴아미드 화합물
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
ES2258062T3 (es) 2000-10-10 2006-08-16 Wyeth Composicion antihelmintica.
NZ526538A (en) * 2000-12-20 2005-12-23 Novartis Ag Anti-endoparasitic amidoacetonitrils
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
BRPI0409185B1 (pt) * 2003-04-04 2018-05-15 Merial, Inc Formulações veterinárias anti-helmínticas tópicas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010109527A (ko) * 1999-05-12 2001-12-10 빌프리더 하이더 사이클릭 뎁시펩타이드 및 피페라진을 함유하는내부기생충 구제용 상승적 배합물
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation

Also Published As

Publication number Publication date
CN1893919B (zh) 2010-09-29
PE20050919A1 (es) 2005-12-16
WO2005055973A2 (de) 2005-06-23
UA85574C2 (uk) 2009-02-10
WO2005055973A3 (de) 2005-08-11
MY142044A (en) 2010-08-30
RU2401108C2 (ru) 2010-10-10
EP1694291A2 (de) 2006-08-30
IL176151A0 (en) 2006-10-05
HK1102915A1 (en) 2007-12-07
ZA200604744B (en) 2007-09-26
PT1694291E (pt) 2010-01-18
BRPI0417578B1 (pt) 2015-12-22
SI1694291T1 (sl) 2010-03-31
CA2548897A1 (en) 2005-06-23
ES2334920T3 (es) 2010-03-17
UY28662A1 (es) 2005-07-29
DK1694291T3 (da) 2010-03-15
BRPI0417578A (pt) 2007-03-20
CN1893919A (zh) 2007-01-10
DE502004010367D1 (de) 2009-12-24
JP4842141B2 (ja) 2011-12-21
AR046878A1 (es) 2005-12-28
AU2004296537B2 (en) 2010-05-13
CA2548897C (en) 2012-04-10
GT200400264A (es) 2005-08-18
HRP20100056T1 (hr) 2010-03-31
MXPA06006594A (es) 2006-08-23
EP1694291B1 (de) 2009-11-11
DE10358525A1 (de) 2005-07-07
CR8428A (es) 2006-11-23
US7763583B2 (en) 2010-07-27
US20070060509A1 (en) 2007-03-15
RU2006124964A (ru) 2008-01-20
KR20060103953A (ko) 2006-10-04
JP2007513903A (ja) 2007-05-31
NO20063171L (no) 2006-07-07
AU2004296537A1 (en) 2005-06-23
ATE447940T1 (de) 2009-11-15
NZ547837A (en) 2010-02-26
IL176151A (en) 2013-12-31
TWI341202B (en) 2011-05-01
TW200533384A (en) 2005-10-16
PL1694291T3 (pl) 2010-04-30

Similar Documents

Publication Publication Date Title
KR101272139B1 (ko) 국소 적용용 체내기생충 구제제
NO342645B1 (no) Sammensetninger, fremgangsmåte for fremstilling derav, og anvendelse derav for å kontrollere endoparasitter
KR100755414B1 (ko) 체내기생충 구제제

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20160427

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20170601

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20170601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000